These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 21690623)

  • 41. An improved method of vancomycin administration to dialysis patients.
    Edell LS; Westby GR; Gould SR
    Clin Nephrol; 1988 Feb; 29(2):86-7. PubMed ID: 3359698
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Linezolid for the treatment of infections caused by Gram-positive pathogens in China.
    Lin DF; Zhang YY; Wu JF; Wang F; Zheng JC; Miao JZ; Zheng LY; Sheng RY; Zhou X; Shen HH; Ijzerman MM; Croos-Dabrera RV; Sheng W
    Int J Antimicrob Agents; 2008 Sep; 32(3):241-9. PubMed ID: 18635341
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Vancomycin pharmacokinetics in critically ill patients receiving continuous venovenous haemodiafiltration.
    DelDot ME; Lipman J; Tett SE
    Br J Clin Pharmacol; 2004 Sep; 58(3):259-68. PubMed ID: 15327585
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Optimizing antimicrobial therapy for gram-positive bloodstream infections in patients on hemodialysis.
    Pai AB; Pai MP
    Adv Chronic Kidney Dis; 2006 Jul; 13(3):259-70. PubMed ID: 16815231
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An update on vancomycin dosing and monitoring practices in hemodialysis patients.
    Zhang M; Dresser L; Battistella M
    CANNT J; 2013; 23(4):25-7; quiz 28-9. PubMed ID: 24660521
    [No Abstract]   [Full Text] [Related]  

  • 46. Vancomycin dosing for pneumonia in critically ill trauma patients.
    Patanwala AE; Norris CJ; Nix DE; Kopp BJ; Erstad BL
    J Trauma; 2009 Oct; 67(4):802-4. PubMed ID: 19820588
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Concentrations of vancomycin in human bone.
    Borner K; Hahn F; Koeppe P
    J Chemother; 1989 Jul; 1(4 Suppl):588-9. PubMed ID: 16312546
    [No Abstract]   [Full Text] [Related]  

  • 48. Trough concentrations of vancomycin: adult therapeutic targets are not appropriate for children.
    Gordon CL; Thompson C; Carapetis JR; Turnidge J; Kilburn C; Currie BJ
    Pediatr Infect Dis J; 2012 Dec; 31(12):1269-71. PubMed ID: 22828642
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevalence of vancomycin-resistant enterococci colonization and its risk factors in chronic hemodialysis patients in Shiraz, Iran.
    Assadian O; Askarian M; Stadler M; Shaghaghian S
    BMC Infect Dis; 2007 Jun; 7():52. PubMed ID: 17553129
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of a vancomycin dosing nomogram based on the Modification of Diet in Renal Disease equation in intensive care unit patients.
    Golenia BS; Levine AR; Moawad IM; Yeh DD; Arpino PA
    J Crit Care; 2013 Oct; 28(5):710-6. PubMed ID: 23499418
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of continuous infusion versus intermittent infusion of vancomycin in patients with methicillin-resistant Staphylococcus aureus.
    Jaruratanasirikul S; Julamanee J; Sudsai T; Saengsuwan P; Jullangkoon M; Ingviya N; Jarumanokul R
    J Med Assoc Thai; 2010 Feb; 93(2):172-6. PubMed ID: 20301996
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dosage adjustment of antiinfective therapy in patients with renal impairment.
    Eckhardt A; Borner K; Keller F; Zellner D
    Int J Clin Pharmacol Ther; 1997 Mar; 35(3):99-102. PubMed ID: 9088997
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Health economics assessment study of teicoplanin versus vancomycin in Gram-positive infections.
    Portolés A; Palau E; Puerro M; Vargas E; Picazo JJ
    Rev Esp Quimioter; 2006 Mar; 19(1):65-75. PubMed ID: 16688294
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of 3 vancomycin dosage regimens during hemodialysis with cellulose triacetate dialyzers: post-dialysis versus intradialytic administration.
    Mason NA; Neudeck BL; Welage LS; Patel JA; Swartz RD
    Clin Nephrol; 2003 Aug; 60(2):96-104. PubMed ID: 12940611
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vancomycin dosing in patients undergoing maintenance hemodialysis.
    Rymarz A; Brodowska-Kania D; Gomółka M; Józefczak-Bergier E; Dzierżanowska M; Niemczyk S
    Int Urol Nephrol; 2014 Aug; 46(8):1681-2. PubMed ID: 24696106
    [No Abstract]   [Full Text] [Related]  

  • 56. Usefulness of serum cystatin C to determine the dose of vancomycin in critically ill patients.
    Suzuki A; Imanishi Y; Nakano S; Niwa T; Ohmori T; Shirai K; Yoshida S; Furuta N; Takemura M; Ito H; Ieiri I; Seishima M; Ogura S; Itoh Y
    J Pharm Pharmacol; 2010 Jul; 62(7):901-7. PubMed ID: 20636878
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Vancomycin dosing in hemodialysis patients].
    Castellano I; González Castillo PM; Covarsí A; Martínez Sánchez J; Suárez Santisteban MA; Gallego S; Marigliano N
    Nefrologia; 2008; 28(6):607-12. PubMed ID: 19016633
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vancomycin continuous infusion as prophylaxis for vascular surgery.
    Payne CJ; Carmichael SJ; Stearns AT; Kingsmore DB; Byrne DS; Binning AR
    Ther Drug Monit; 2009 Dec; 31(6):786-8. PubMed ID: 19809387
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Monitoring of vancomycin serum levels for the treatment of staphylococcal infections.
    Kitzis MD; Goldstein FW
    Clin Microbiol Infect; 2006 Jan; 12(1):92-5. PubMed ID: 16460555
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A Bayesian Model to Describe Factors Influencing Trough Levels of Vancomycin in Hemodialysis Patients.
    Sansot C; Kalbacher E; Lemoine S; Bourguignon L; Fauvel JP; Ducher M
    Nephron; 2015; 131(2):131-7. PubMed ID: 26376164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.